NicheSphere reveals Spp1⁺ macrophages as central hubs coordinating fibrotic remodeling in myeloproliferative neoplasms

Using a novel computational framework called NicheSphere, this study identifies Spp1⁺ macrophages as central communication hubs that coordinate fibrotic remodeling in myeloproliferative neoplasms by integrating inflammatory and fibrotic signaling with stromal cells, revealing them as promising therapeutic targets for bone marrow fibrosis.

The Gist

The Big Picture: A Construction Site Gone Wrong

Imagine your bone marrow is a busy construction site. Its job is to build new blood cells (the workers) and keep the area clean and organized.

In a disease called Myeloproliferative Neoplasm (MPN), specifically a type called Myelofibrosis, this construction site goes haywire. Instead of building workers, the site gets covered in thick, hard concrete (scar tissue). This "concrete" is called fibrosis. It squeezes out the healthy workers, stops new ones from being made, and causes the body to fail.

For a long time, scientists knew that this happened, but they didn't fully understand who was the foreman giving the bad orders to pour all that concrete.

The New Discovery: The "Super-Connector" Macrophage

This paper found the answer. The foreman is a specific type of immune cell called a macrophage (a cell that usually eats up trash and bacteria). But in this disease, a special group of them, marked by a protein called Spp1, turns into a "Super-Connector."

Think of these Spp1+ macrophages as the central hub of a chaotic social network. They are the people at the party who know everyone, stand in the middle of the room, and whisper instructions to the builders, the security guards, and the cleanup crew all at once.

How They Did It: The "Double-Cell" Detective Work

Studying cells inside the bone marrow is like trying to understand a conversation in a crowded, dark room where everyone is moving fast. Usually, scientists take cells apart one by one to read their "diaries" (genetic code), but this loses the context of who was talking to whom.

The researchers used a clever trick called PIC-seq (Physically Interacting Cell sequencing).

• The Analogy: Imagine they didn't just take photos of people alone; they took photos of people holding hands.
• They tagged the "bad" blood cells with Green and the "fibrosis-driving" cells with Red.
• When they found cells that were Green AND Red (physically touching), they knew these two cells were having a direct conversation.
• They then used a new computer tool they invented called NicheSphere to map these conversations. It's like turning a messy room of shouting people into a clear organizational chart showing exactly who is influencing whom.

The Story of the Spp1 Hub

Here is what the "NicheSphere" map revealed:

1. The Two Teams: The bone marrow has two main groups:
   • The Inflammatory Team: Cells that scream "Fire!" (causing inflammation).
   • The Construction Team: Cells that lay down the concrete (fibrosis).
2. The Bridge: The Spp1+ macrophage is the bridge. It sits right in the middle.
   • It talks to the Inflammatory Team and says, "Keep screaming! Make more noise!" (Releasing a chemical called IL-1β).
   • It talks to the Construction Team and says, "Pour more concrete!" (Releasing a chemical called Spp1/Osteopontin).
3. The Vicious Cycle: The Construction Team listens, pours more concrete, and then screams back, "We need more Spp1!" This creates a feedback loop where the scar tissue gets thicker and thicker, and the inflammation never stops.

The Experiment: Cutting the Wire

To prove this theory, the scientists ran two experiments:

• Experiment 1: They removed the "Spp1" ability from the Construction Team (the stromal cells). Result: The concrete pouring slowed down.
• Experiment 2: They removed the "Spp1" ability from the Inflammatory Team (the blood cells/macrophages). Result: The screaming stopped, the inflammation died down, and the concrete pouring stopped too.

The Lesson: You have to cut the wire on both sides to stop the machine. The Spp1 macrophage is the glue holding the inflammation and the scarring together.

Why This Matters for Humans

The researchers didn't just stop at mice. They looked at human patients with MPN.

• The Blood Test: They found that patients with high levels of Spp1 in their blood were the ones who got sick the fastest.
• The Prediction: High Spp1 levels were a crystal ball; they predicted that a patient would likely pass away sooner.

The Takeaway

This paper changes the game. Instead of just trying to stop the "bad blood cells" (the mutant clone), doctors might be able to stop the Spp1 macrophages.

If we can find a drug to silence this "Super-Connector," we could break the cycle. We could stop the inflammation from screaming and the construction crew from pouring concrete, potentially saving the bone marrow from turning into a solid block of scar tissue.

In short: They found the "glue" holding a deadly disease together, mapped exactly how it works, and showed that removing this glue could save the construction site.

Technical Summary

1. Problem Statement

Myeloproliferative neoplasms (MPNs), particularly Primary Myelofibrosis (PMF), are driven by somatic mutations (e.g., JAK2, CALR, MPL) that lead to clonal expansion and progressive bone marrow (BM) fibrosis. While the role of mutant hematopoietic clones and cytokine secretion (e.g., PF4) in driving fibrosis is established, the spatial architecture and direct physical interactions between hematopoietic cells and the fibrosis-driving stromal niche remain poorly understood.

• Limitations of Current Methods: Conventional single-cell RNA sequencing (scRNA-seq) loses spatial context. Spatial transcriptomics often fail in bone marrow due to the need for decalcification (compromising RNA integrity) and the dense, heterogeneous nature of the marrow.
• Computational Gap: Existing tools for analyzing cell-cell interactions (e.g., ligand-receptor inference) do not account for direct physical contacts or effectively quantify how these interactions change between homeostasis and disease states using multiplet/doublet data.

2. Methodology

The authors employed a multi-modal experimental and computational approach to map the cellular ecosystem of PMF:

A. Experimental Design (PIC-seq)

• Dual Lineage Tracing: They utilized a mouse model where Pf4-ZsGreen+ hematopoietic cells (tracking megakaryocytes, monocytes, macrophages, granulocytes) were transduced with a TPO-overexpression vector (to induce MPN/fibrosis) and transplanted into Gli1-tdTomato+ recipient mice (tracking fibrosis-driving stromal cells).
• Physical Interaction Cell Sequencing (PIC-seq): A gentle dissociation protocol was developed to isolate:
  1. Singlets: Pf4+ cells, Gli1+ cells.
  2. Multiplets (Doublets): Physically interacting Pf4+/Gli1+ cells.
• Sequencing: 10x Genomics scRNA-seq was performed on both singlets and multiplets to capture transcriptional programs of isolated cells and their direct interaction partners.

B. Computational Innovation: NicheSphere
To analyze the PIC-seq data, the authors developed NicheSphere, a novel computational framework that:

• Deconvolution: Uses algorithms (e.g., BayesPrism) to assign cell type identities to multiplets based on singlet references.
• Co-localization Network: Constructs a graph where nodes are cell types and edge weights represent the statistical significance of interaction changes between disease (TPO) and control (EV) conditions.
• Niche Identification: Clusters cells into "communication hubs" or "niches" based on differential co-localization probabilities.
• Process-Constrained Communication: Integrates curated ligand-receptor (LR) databases (specifically for ECM, immune recruitment, and cytokines) to map biological processes driving these spatial interactions.

C. Validation Models

• Genetic Ablation: Performed conditional knockouts of Spp1 (Osteopontin) in either the stromal compartment or the hematopoietic compartment to dissect the source-specific contribution to fibrosis.
• In Vitro Models: Used FL-HoxB8 immortalized progenitor cells with MPL mutations to study cell-autonomous effects of Spp1 loss on macrophage function (phagocytosis, cytokine secretion).
• Clinical Correlation: Analyzed plasma SPP1 levels in MPN patients (UK Biobank and local cohorts) to assess prognostic value.

3. Key Contributions

1. Development of NicheSphere: A new open-source tool that uniquely combines physical co-localization data (from multiplets) with ligand-receptor communication analysis to define disease-specific cellular niches.
2. Identification of Spp1⁺ Macrophages: Revealed a specific macrophage subset (Spp1⁺/CD68⁺/Trem2⁺/Fabp5⁺) as the central "communication hub" bridging inflammatory and fibrotic programs.
3. Mechanistic Insight: Elucidated a bidirectional feed-forward loop where stromal and hematopoietic Spp1 cooperate to drive fibrosis via integrin-mediated adhesion and IL-1β signaling.

4. Key Results

A. Spatial Architecture of Fibrosis

• NicheSphere identified four distinct communication niches in TPO-induced fibrosis:
  1. Fibroblast-Infiltrating Macrophage Niche: Enriched in inflammatory pathways (WNT, JAK-STAT, TNFα).
  2. Macrophage Niche: Resident-like and Ly6C-low macrophages.
  3. Fibrosis-Interacting Core: The central hub containing Spp1⁺ macrophages, osteoCAR cells, fibroblasts, and megakaryocytes. This niche showed increased co-localization in disease and was enriched for TGF-β and ECM glycoproteins.
  4. Neutrophil Niche.
• Spp1⁺ Macrophages emerged as the top "hub" (highest betweenness centrality), physically connecting the inflammatory macrophage niche with the pro-fibrotic stromal core.

B. Molecular Mechanisms

• Ligand-Receptor Axis: Spp1 (Osteopontin) acts as a dominant ligand binding to integrins (Itgav, Itga9, etc.) and CD44 on stromal cells.
• Signaling Loop:
  • Spp1⁺ macrophages secrete Spp1, promoting integrin-mediated adhesion and activating resident macrophages.
  • Activated macrophages upregulate IL-1β.
  • IL-1β stimulates stromal cells (fibroblasts/osteoCARs) to express Spp1 and Col1a1 (collagen), creating a positive feedback loop.
  • Note: TGF-β induces myofibroblast activation but downregulates Spp1, suggesting IL-1β is the specific driver of the Spp1-fibrosis axis.

C. Genetic Ablation Studies

• Stromal Spp1 KO: Reduced BM fibrosis, normalized cellularity, decreased splenomegaly, and improved anemia.
• Hematopoietic Spp1 KO: Reduced circulating monocytes, decreased IL-1β levels, and restored normal macrophage phagocytic function (which was hyperactive in the disease state).
• Conclusion: Both stromal and hematopoietic sources of Spp1 are required for full disease progression, acting cooperatively.

D. Clinical Relevance

• Human Data: Plasma SPP1 levels are significantly elevated in MPN patients compared to healthy controls, regardless of driver mutation (JAK2 vs. CALR).
• Prognosis: In the UK Biobank cohort, higher baseline SPP1 levels correlated with increased mortality and shorter survival in MPN patients, establishing SPP1 as a potential prognostic biomarker.

5. Significance

• Paradigm Shift: The study moves beyond cell-intrinsic transcriptional changes to emphasize spatially organized cell communities. It demonstrates that Spp1⁺ macrophages are not passive bystanders but active organizers of the fibrotic niche.
• Therapeutic Target: The identification of the SPP1-Integrin/CD44 axis and the IL-1β loop provides a novel therapeutic strategy. Targeting SPP1 could simultaneously disrupt the mutated clone's inflammatory output and the stromal fibrotic response.
• Methodological Advance: NicheSphere sets a new standard for analyzing cell-cell interactions in complex tissues where physical contact is critical, overcoming the limitations of traditional scRNA-seq and spatial transcriptomics in the bone marrow.

In summary, this paper defines Spp1⁺ macrophages as the central "glue" in myelofibrosis, integrating inflammation and fibrosis through a specific spatial and molecular network, and validates SPP1 as a critical therapeutic target and prognostic marker.